These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32611374)

  • 21. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
    Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
    Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer.
    Wang W; Jo H; Park S; Kim H; Kim SI; Han Y; Lee J; Seol A; Kim J; Lee M; Lee C; Dhanasekaran DN; Ahn T; Song YS
    Cancer Lett; 2022 Aug; 542():215735. PubMed ID: 35569696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer.
    Maeda K; Sasaki H; Ueda S; Miyamoto S; Terada S; Konishi H; Kogata Y; Ashihara K; Fujiwara S; Tanaka Y; Tanaka T; Hayashi M; Ito Y; Kondo Y; Ochiya T; Ohmichi M
    J Ovarian Res; 2020 Apr; 13(1):47. PubMed ID: 32336272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.
    Marchini S; Cavalieri D; Fruscio R; Calura E; Garavaglia D; Fuso Nerini I; Mangioni C; Cattoretti G; Clivio L; Beltrame L; Katsaros D; Scarampi L; Menato G; Perego P; Chiorino G; Buda A; Romualdi C; D'Incalci M
    Lancet Oncol; 2011 Mar; 12(3):273-85. PubMed ID: 21345725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
    Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
    Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.
    Gao YC; Wu J
    Tumour Biol; 2015 Jun; 36(6):4843-50. PubMed ID: 25636451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients.
    Petersen PHD; Lopacinska-Jørgensen J; Høgdall CK; Høgdall EV
    Mol Biol Rep; 2023 Dec; 50(12):10235-10247. PubMed ID: 37934368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis.
    Petri AL; Simonsen AH; Høgdall E; Christensen IJ; Kjaer SK; Yip C; Risum S; Pedersen AT; Hartwell D; Fung ET; Høgdall C
    Proteomics Clin Appl; 2010 Mar; 4(3):304-14. PubMed ID: 21137051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma.
    Ostmeyer J; Lucas E; Christley S; Lea J; Monson N; Tiro J; Cowell LG
    PLoS One; 2020; 15(3):e0229569. PubMed ID: 32134923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-200c and microRNA-31 regulate proliferation, colony formation, migration and invasion in serous ovarian cancer.
    Ibrahim FF; Jamal R; Syafruddin SE; Ab Mutalib NS; Saidin S; MdZin RR; Hossain Mollah MM; Mokhtar NM
    J Ovarian Res; 2015 Aug; 8():56. PubMed ID: 26260454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.
    Zuberi M; Khan I; Gandhi G; Ray PC; Saxena A
    Tumour Biol; 2016 Aug; 37(8):11259-66. PubMed ID: 26951510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features.
    Xu S; Xu P; Wu W; Ou Y; Xu J; Zhang G; Li J; Xu G
    Curr Pharm Des; 2014; 20(11):1888-95. PubMed ID: 23888941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
    Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
    Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of miR-141 and miR-200a Increase
    Wahab NA; Othman Z; Nasri NWM; Mokhtar MH; Ibrahim SF; Hamid AA; Raja Ali RA; Mokhtar NM
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboplatin with Decitabine Therapy, in Recurrent Platinum Resistant Ovarian Cancer, Alters Circulating miRNAs Concentrations: A Pilot Study.
    Benson EA; Skaar TC; Liu Y; Nephew KP; Matei D
    PLoS One; 2015; 10(10):e0141279. PubMed ID: 26485143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
    Prahm KP; Høgdall C; Karlsen MA; Christensen IJ; Novotny GW; Høgdall E
    PLoS One; 2018; 13(11):e0207319. PubMed ID: 30475821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exosomal microRNAs as tumor markers in epithelial ovarian cancer.
    Pan C; Stevic I; Müller V; Ni Q; Oliveira-Ferrer L; Pantel K; Schwarzenbach H
    Mol Oncol; 2018 Nov; 12(11):1935-1948. PubMed ID: 30107086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
    Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Prognostic and Predictive Significance of Circulating MicroRNAs in Ovarian Cancer Patients.
    Halvorsen AR; Kristensen G; Embleton A; Adusei C; Barretina-Ginesta MP; Beale P; Helland Å
    Dis Markers; 2017; 2017():3098542. PubMed ID: 28293063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.